What are the indications and dosing guidelines for Clonidine (antihypertensive medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clonidine: Indications and Dosing Guidelines

Clonidine is primarily indicated for the treatment of hypertension, with specific applications in hypertensive emergencies, menopausal hot flashes, and as an adjunctive therapy for ADHD in children. The dosing and administration vary based on the indication and patient population.

Hypertension Management

Initial Dosing

  • Adults: 0.1 mg tablet twice daily (morning and bedtime) 1
  • Elderly patients: May benefit from a lower initial dose 1
  • Maintenance dose: Increments of 0.1 mg per day at weekly intervals until desired response is achieved 1
  • Therapeutic range: 0.2 mg to 0.6 mg daily in divided doses 1
  • Maximum effective daily dose: 2.4 mg, though doses this high are rarely used 1

Administration Tips

  • Taking the larger portion of the daily dose at bedtime minimizes side effects like dry mouth and drowsiness 1
  • For patients with renal impairment, start with a lower initial dose and monitor carefully 1
  • No supplemental dosing needed following hemodialysis 1

Hypertensive Emergencies

Oral Loading Protocol

  • Initial dose: 0.1-0.2 mg 2
  • Follow with hourly doses of 0.05-0.1 mg until target BP is reached or maximum 0.7 mg total dose 2
  • Achieves significant BP reduction in 93% of patients 2
  • Mean effective dose in studies: 0.32 mg with response time of 1.8 hours 3

Advantages in Hypertensive Urgencies

  • Smooth, rapid, predictable BP reduction
  • Lower cost compared to IV medications
  • Reduced need for hospitalization
  • Minimal clinically significant side effects 2

Menopausal Hot Flashes

Dosing for Hot Flashes

  • Transdermal: 0.1 mg/day 4
  • Oral: 0.1 mg/day 4
  • Efficacy: Reduces hot flashes by up to 46% 4

Comparative Efficacy

  • Less effective than gabapentin or SSRI/SNRIs for hot flashes 4
  • Mean difference in daily hot flashes vs. placebo: -0.95 (95% CI: -1.44 to -0.47) 4

ADHD in Children

Dosing for ADHD

  • Starting dose: 0.05 mg (half tablet) at bedtime 4
  • Maximum recommended dose: 0.3 mg/day 4
  • Administration: Either at bedtime for sleep or 4 times daily for behavioral control 4

Precautions for ADHD Use

  • Obtain full medical history of patient and first-degree family members 4
  • History of sudden death, repeated fainting, or arrhythmias in family members may contraindicate use 4

Side Effects and Monitoring

Common Side Effects

  • Sedation and dry mouth (most common, dose-related) 5
  • Other effects: drowsiness (28%), constipation (13%), dizziness (9%) 6
  • Side effects typically diminish over time, with reduced prevalence after long-term use 6

Serious Considerations

  • Rebound hypertension with abrupt discontinuation
  • Taper gradually over 2-4 weeks when discontinuing 7
  • For doses ≤0.4 mg/day: reduce by 0.1 mg/day each week 7
  • For doses >0.4 mg/day: more extended taper of 4-6 weeks recommended 7

Special Populations

Elderly Patients

  • Start with lower initial doses 1
  • More gradual tapering when discontinuing (0.1 mg reduction every 2 weeks) 7

Patients with Cardiovascular Disease

  • Can be safely given to patients with congestive heart failure and ischemic heart disease 5
  • More careful monitoring during tapering 7

Drug Interactions and Contraindications

  • Avoid concurrent beta-blocker withdrawal (withdraw beta-blocker several days before beginning clonidine taper) 7
  • Safe for use in patients with obstructive lung disease, chronic renal insufficiency, and diabetes mellitus 5

Clonidine's versatility makes it valuable across multiple indications, but careful attention to dosing, monitoring, and discontinuation protocols is essential for safe and effective use.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clonidine hydrochloride.

Southern medical journal, 1982

Guideline

Clonidine Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.